Biotech giant Amgen to open innovation site in India
Thousand Oaks-based Amgen will be opening a new technology and innovation site in Hyderabad, India, the biotech giant announced Aug. 9. Known as Amgen India, the site will further advance Amgen’s pipeline of medicines and will be located in HITEC City, a suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110. In a Read More →
Live Data keeps real-time information on employment status
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Barbara nonprofit legends to step down
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Werft to step down as Cottage Health CEO
Ron Werft, the man who has helmed Santa Barbara-based Cottage Health for nearly three decades, has announced that he will be stepping down as president and CEO in 2025. Announced July 29, Werft has served as Cottage Health’s president and CEO for the past 24 years. He has worked at Cottage Health for 37 years. Read More →
Latigo taps Farzan for CEO post
The common saying goes “The third time’s a charm” but for Nima Farzan, he’s looking to go 3-for-3 successfully running biotechnology companies. On July 22, Farzan was appointed to be Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, first CEO. Farzan’s experience spans more than two decades long in the biopharmaceutical industry, including being the Read More →
Thousand Oaks biotech company appoints CEO
Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, announced that it has appointed Nima Farzan to be its CEO. Announced July 22, Farzan brings a “strong track record” with more than two decades of leadership experience in the biopharmaceutical industry. Farzan is also Latigo’s first CEO as he replaces Desmond Padhi, operating partner Read More →
Conejo Valley biotech’s passage to India
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
